Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Aerocrine AB · Predicate Candidate Screening

6 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

141 daysmedian FDA review time
321 days90th percentile
6clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K150233NIOX VERO Airway Inflammation MonitorAerocrine AB2015-02-26240
K133898NIOX VERO AIRWAY INFLAMMATION MONITORAerocrine AB2014-11-063210
K123683NIOX PANEL FOR USE WITH THE NIOX MINO AIRWAY INFLAMMATION MOAerocrine AB2012-12-27270
K101034NIOX MINO MODEL 09-1000Aerocrine AB2010-09-021410
K072816NIOX MINOAerocrine AB2008-03-031530
DEN030001NIOX ARTICLE NO: 02-1000Aerocrine AB2003-04-30430

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda